Humanigen Inc (HGEN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access HGEN Annual Cash Flow →
Looking at cash flow data from Humanigen Inc through Mar 31 2022 provides insight into Mar 31 2023's financial flexibility across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2023)
3 Months
(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Operating Activities
Income-4.18
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-0.22
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.22
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Change In Fair Value Of Preferred Stock Warrant Liability-
Increase Decrease In Accrued Clinical And Research-
Noncash Interest Expense Income Net-
Gain Loss On Disposition Of Property-
Modified Stock Options Due To Executive Severance-
Modified Stock Options Due To Restructuring Activities-
Debtor Reorganization Items Debtor In Possession Facility Financing Costs-
Investment Income Amortization Of Premium-
Increase Decrease In Deferred Rent-
Issuance Of Warrants In Connection With Acquisition Of Licenses-
Issuance Of Common Stock In Exchange For Services-
Issuance Of Common Stock In Lieu Of Cash Compensation0.08
Gain On Forgiveness Of Accrued Legal Fees-
Debt Conversion Converted Instrument Amount4.32
Issuance In Stock Options For Payment Of Accrued Compensation0.18
Beneficial Conversion Feature Of Advance Notes-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-2.13
Increase (Decrease) in Accrued Liabilities-0.77
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other-0.98
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-7.06
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Notes Issued-
Proceeds From Bridge Notes0.35
Payments On Bridge Notes-2.40
Repayment Of A Term Loan To Hercules-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-7.06
Total Cash Flow-7.06
4 historic quarters locked

Sign in to unlock the full Humanigen Inc cash flow history.

About Humanigen Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001214659-23-007002

Figures are derived from filed reports and may be restated. Historical data is subject to revision.